Filing Details

---

^* Percentage calculated based on 13,640,374 shares of common stock, par value $0.06 per share, outstanding as of April 29, 2022, as reported in the Form 10-Q for the quarter ended March 31, 2022, of Cedar Realty Trust, Inc.

---

^* Percentage calculated based on 13,640,374 shares of common stock, par value $0.06 per share, outstanding as of April 29, 2022, as reported in the Form 10-Q for the quarter ended March 31, 2022, of Cedar Realty Trust, Inc.

^* Percentage calculated based on 13,640,374 shares of common stock, par value $0.06 per share, outstanding as of April 29, 2022, as reported in the Form 10-Q for the quarter ended March 31, 2022, of Cedar Realty Trust, Inc.

^* Percentage calculated based on 13,640,374 shares of common stock, par value $0.06 per share, outstanding as of April 29, 2022, as reported in the Form 10-Q for the quarter ended March 31, 2022, of Cedar Realty Trust, Inc.

---

^* Percentage calculated based on 13,640,374 shares of common stock, par value $0.06 per share, outstanding as of April 29, 2022, as reported in the Form 10-Q for the quarter ended March 31, 2022, of Cedar Realty Trust, Inc.

EXPLANATORY NOTE

This Amendment No. 9 (this “Amendment”) amends and supplements the Schedule 13D filed on November 9, as amended on February 2, 2021, March 2, 2021, April 21, 2021, July 7, 2021, August 18, 2021, January 17, 2022, June 27, 2022, and July 5^th, 2022 (the “Schedule 13D”), by the Reporting Persons relating to the common stock, par value $0.06 per share (the “Common Stock”), of Cedar Realty Trust, Inc. (the “Issuer”). Information reported in the Schedule 13D remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment. Capitalized terms used but not defined in this Amendment have the respective meanings set forth in the Schedule 13D.

Item 2.

Identity and Background

Item 2 is amended and restated as follows:

Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.” Camac Partners, Camac Capital, Camac Fund, Camac Fund II and Mr. Shahinian are referred to collectively as “Camac.”

Item 3 is amended and restated as follows:

The shares of Common Stock purchased by Camac Fund and Camac Fund II were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 646,026 shares of Common Stock beneficially owned by Camac Fund and Camac Fund II is approximately $7,229,280, including brokerage commissions.

Item 4 is amended and restated as follows:

The Reporting Persons purchased the securities of the Issuer reported herein based on the Reporting Persons' belief that such securities, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of securities of the Issuer at prices that would make the purchase or sale of such securities desirable, the Reporting Persons may endeavor to (i) increase or decrease their respective positions in the Issuer through, among other things, the purchase or sale of securities of the Issuer on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable and/or (ii) enter into transactions that increase or hedge their economic exposure to the securities of the Issuer without affecting their beneficial ownership of the Shares.

No Reporting Person has any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon completion of any of the actions discussed herein. The Reporting Persons intend to review their investments in the Issuer on a periodic basis and may from time to time engage in communications and discussions with management and the Board of Directors of the Issuer (the "Board") and other stockholders of the Issuer concerning, among other things, Board composition and corporate governance, appropriate compensation levels of management and the Board, and the proper utilization of cash flow.

The Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto.

On January 14, 2022, the Reporting Persons entered into the Amendment to Cooperating Agreement with the Issuer and the Investor Group Designees (“Amended Cooperation Agreement”), which amends the Cooperation Agreement dated April 28, 2021, as previously described in the Reporting Persons Schedule 13D Amendment No. 3. The Amended Cooperation Agreement extends the Issuer’s commitment to hold the 2022 Annual Meeting of Stockholders no later than November 30, 2022, extends the Termination date, and additionally the Issuer agrees not to amend Section 2.11 of its Bylaws prior to its 2022 Annual Meeting of Shareholders.

Item 5 is amended and restated as follows:

(a) and (b) The responses of the Reporting Persons to rows 7, 8, 9, 10, 11 and 13 on the cover pages of this Statement are incorporated by reference. As of 9:00 a.m., Eastern time, on July 7, 2022, Camac beneficially owned 646,026 shares of Common Stock, representing approximately 4.7% of the outstanding shares of Common Stock.

Camac Capital, as the general partner of Camac Fund and Camac Fund II, may be deemed to have the power to direct the voting and disposition of the shares of Common Stock beneficially owned by Camac Fund and Camac Fund II, and may be deemed to be the indirect beneficial owner of such shares. Camac Capital disclaims beneficial ownership of such shares for all other purposes.

Camac Partners, as the investment manager of Camac Fund and Camac Fund II, may be deemed to have the power to direct the voting and disposition of the shares of Common Stock beneficially owned by Camac Fund and Camac Fund II, and may be deemed to be the indirect beneficial owner of such shares. Camac Partners disclaims beneficial ownership of such shares for all other purposes.

Mr. Shahinian, as the managing member of Camac Partners, may be deemed to have the power to direct the voting and disposition of the shares of Common Stock beneficially owned by Camac Fund and Camac Fund II, and may be deemed to be the indirect beneficial owner of such shares. Mr. Shahinian disclaims beneficial ownership of such shares for all other purposes.

To the knowledge of each of the Reporting Persons, other than as set forth above, none of the persons named in Item 2 is the beneficial owner of any shares of Common Stock.

(c) Except as set forth in Schedule A, none of the Reporting Persons has effected any transactions in the Common Stock in the 60 days prior to the date of this Amendment.

(d) No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the shares of Common Stock.

(e) Not applicable.

SIGNATURES

After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Dated:  July 7, 2022

---